Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 9/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 9/20 | 0.43 |
| ▸ | MAPT | P10636 | 7/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | HPGD | P15428 | 5/20 | 0.43 |
| ▸ | LPL | P06858 | 2/20 | 0.43 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.43 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.43 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 4/20 | 0.40 |
| ▸ | MAOA | P21397 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31156725 | 0.93 | MEN1 (0.45) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL31074774 | 0.92 | LIPG (0.46) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL25864406 | 0.92 | LPL (0.45) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL38659883 | 0.90 | LPL (0.50) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL27369240 | 0.89 | ALDH1A1 (0.43) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL28435127 | 0.88 | LIPG (0.47) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL27369208 | 0.88 | LIPG (0.47) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL27403487 | 0.86 | LPL (0.45) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL17529962 | 0.85 | LPL (0.47) | MEN1KMT2AMAPTALDH1A1HPGD | |
| SCHEMBL31622782 | 0.85 | MEN1 (0.40) | MEN1KMT2AMAPTALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026101205-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 솔루스첨단소재 주식회사 | 2026-05-15 | — | — | WO | disclosed |
| EP-4600325-B1 | ORGANIC LIGHT-EMITTING COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | SOLUS ADVANCED MATERIALS CO LTD (KR) | 2026-04-29 | — | — | EP | disclosed |
| EP-4600325-A1 | ORGANIC LIGHT-EMITTING COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | Solus Advanced Materials Co., Ltd. (KR) | 2025-08-13 | — | — | EP | disclosed |
| WO-2025135309-A1 | ORGANIC LIGHT-EMITTING COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | 솔루스첨단소재 주식회사 | 2025-06-26 | — | — | WO | disclosed |
| WO-2025135308-A1 | ORGANIC LIGHT-EMITTING COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | 솔루스첨단소재 주식회사 | 2025-06-26 | — | — | WO | disclosed |
| US-11873294-B2 | Compound containing anthrone and nitrogen-containing heterocycle and application in OLED devices | JIANGSU SUNERA TECHNOLOGY CO., LTD. (CN) | 2024-01-16 | — | — | US | disclosed |
| US-11873294-B2 | Compound containing anthrone and nitrogen-containing heterocycle and application in OLED devices | JIANGSU SUNERA TECHNOLOGY CO., LTD. (CN) | 2024-01-16 | — | — | US | disclosed |
| WO-2021049843-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2021-03-18 | — | — | WO | disclosed |
| US-20200354347-A1 | Compound containing anthrone and nitrogen-containing heterocycle and application in OLED devices | VALIANT CO., LTD. (CN) | 2020-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200354347-A1 | Compound containing anthrone and nitrogen-containing heterocycle and application in OLED devices | NLRP1, OCIAD2, OCIAD1 | MEN1 2968/4885KMT2A 3936/4885MAPT 2568/4885 |
| US-11873294-B2 | Compound containing anthrone and nitrogen-containing heterocycle and application in OLED devices | NLRP1, OCIAD2, OCIAD1 | MEN1 2968/4885KMT2A 3936/4885MAPT 2568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.